{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:09:23Z","timestamp":1776820163487,"version":"3.51.2"},"reference-count":37,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CPP-329455-107837"],"award-info":[{"award-number":["CPP-329455-107837"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PHE148161"],"award-info":[{"award-number":["PHE148161"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["16743"],"award-info":[{"award-number":["16743"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["18270"],"award-info":[{"award-number":["18270"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["2012-5139 (HSR)"],"award-info":[{"award-number":["2012-5139 (HSR)"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,9,23]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Pharmacists were acknowledged as the most appropriate healthcare professional to dispense mifepristone for medication abortion shortly after the prescription therapy became available in January 2017 in Canada.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to identify the facilitators and barriers for successful initiation and ongoing dispensing of mifepristone among community pharmacists across Canada.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Study design<\/jats:title>\n                  <jats:p>We surveyed community pharmacists from urban\/rural practice settings across Canada by recruiting from January 2017 to January 2019 through pharmacist organisations, professional networks, at mifepristone training courses and at professional conferences. The Diffusion of Innovations theory informed the study design, thematic analysis and interpretation of findings. We summarised categorical data using counts and proportions, \u03c7<jats:sup>2<\/jats:sup> tests, Wilcoxon rank-sum and proportional odds logistic regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 433 responses from dispensing community pharmacists across 10\/13 Canadian provinces and territories, 93.1% indicated they were willing and ready to dispense mifepristone. Key facilitators were access to a private consultation setting (91.4%), the motivation to increase accessibility for patients (87.5%) and to reduce pressure on the healthcare system (75.3%). The cost of the mifepristone\/misoprostol product was an initial barrier, subsequently resolved by universal government subsidy. A few pharmacists mentioned liability, lack of prescribers or inadequate stock as barriers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Pharmacist respondents from across Canada reported being able and willing to dispense mifepristone and rarely mentioned barriers to stocking\/dispensing the medication in the community pharmacy setting. The removal of initial regulatory obstacles to directly dispense mifepristone to patients facilitated the provision of medication abortion in the primary care setting.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-063370","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T12:09:42Z","timestamp":1665144582000},"page":"e063370","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists"],"prefix":"10.1136","volume":"12","author":[{"given":"Enav Z","family":"Zusman","sequence":"first","affiliation":[{"name":"Collaboration for Outcomes Research and Evaluation, The University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver, British Columbia, Canada"},{"name":"Department of Obstetrics and Gynaecology, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Munro","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada"},{"name":"Centre for Health Evaluation and Outcome Sciences (CH\u00c9OS), Providence Health Care, Vancouver, British Columbia, Canada"},{"name":"Department of Family Practice, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-7882","authenticated-orcid":false,"given":"Wendy V","family":"Norman","sequence":"additional","affiliation":[{"name":"Department of Family Practice, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Public Health, Environments and Society, London School of Hygiene and Tropical Medicine Faculty of Public Health and Policy, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A","family":"Soon","sequence":"additional","affiliation":[{"name":"Collaboration for Outcomes Research and Evaluation, The University of British Columbia Faculty of Pharmaceutical Sciences, Vancouver, British Columbia, Canada"},{"name":"Department of Family Practice, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,10,7]]},"reference":[{"key":"2025101814181084000_12.10.e063370.1","unstructured":"Induced abortions reported in Canada in 2019 | CIHI. Available: https:\/\/www.cihi.ca\/en\/induced-abortions-reported-in-canada-in-2019"},{"key":"2025101814181084000_12.10.e063370.2","unstructured":"Grant K . Long-Awaited abortion pill Mifegymiso makes Canadian debut. The globe and mail, 2017. Available: https:\/\/www.theglobeandmail.com\/news\/national\/long-awaited-abortion-pill-mifegymiso-rolls-out-in-canada\/article33695167\/ [Accessed 1 Mar 2021]."},{"key":"2025101814181084000_12.10.e063370.3","unstructured":"Health Canada . Health Canada Drug Product Database [Internet]. Mifegymiso Product Monograph. Available: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/drug-product-database.htmlcited2021-03-01"},{"key":"2025101814181084000_12.10.e063370.4","first-page":"e201","article-title":"First-Trimester medical abortion practices in Canada: national survey","volume":"62","author":"Guilbert","year":"2016","journal-title":"Can Fam Physician"},{"key":"2025101814181084000_12.10.e063370.5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S1701-2163(16)32560-9","article-title":"Far From Home? A Pilot Study Tracking Women\u2019s Journeys to a Canadian Abortion Clinic","volume":"29","author":"Sethna","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"2025101814181084000_12.10.e063370.6","unstructured":"United Nations Human Rights Commissioner . Committee on the elimination of discrimination against women: concluding observations on the combined eighth and ninth periodic reports of Canada, 2016. Available: http:\/\/www.etoconsortium.org\/nc\/en\/404\/?tx_drblob_pi1%5BdownloadUid%5D=194 [Accessed 03 Jan 2021]."},{"key":"2025101814181084000_12.10.e063370.7","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160581"},{"key":"2025101814181084000_12.10.e063370.8","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2562"},{"key":"2025101814181084000_12.10.e063370.9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.japh.2018.04.011","article-title":"Medication abortion: potential for improved patient access through pharmacies","volume":"58","author":"Raifman","year":"2018","journal-title":"J Am Pharm Assoc"},{"key":"2025101814181084000_12.10.e063370.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028443"},{"key":"2025101814181084000_12.10.e063370.11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jogc.2019.10.037","article-title":"Barriers and facilitators to the implementation of first trimester medical abortion with mifepristone in the province of Qu\u00e9bec: a qualitative investigation","volume":"42","author":"Wagner","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"2025101814181084000_12.10.e063370.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227216","article-title":"Leadership for success in transforming medical abortion policy in Canada","volume":"15","author":"Dineley","year":"2020","journal-title":"PLoS One"},{"key":"2025101814181084000_12.10.e063370.13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13012-021-01144-w","article-title":"Pharmacist dispensing of the abortion pill in Canada: diffusion of innovation meets integrated knowledge translation","volume":"16","author":"Munro","year":"2021","journal-title":"Implement Sci"},{"key":"2025101814181084000_12.10.e063370.14","unstructured":"Research data capture REDCap BCCHR REDCap. Available: https:\/\/rc.bcchr.ca\/ [Accessed 4 May 2021]."},{"key":"2025101814181084000_12.10.e063370.15","unstructured":"Rogers EM . Diffusion of innovation. 5th ed. New York, NY, USA: Simon Schuster, 2003."},{"key":"2025101814181084000_12.10.e063370.16","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-3-36"},{"key":"2025101814181084000_12.10.e063370.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.0887-378X.2004.00325.x"},{"key":"2025101814181084000_12.10.e063370.18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2015.03.013","article-title":"The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study","volume":"92","author":"Norman","year":"2015","journal-title":"Contraception"},{"key":"2025101814181084000_12.10.e063370.19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/pharmacy2010124","article-title":"Development of a survey to assess the acceptability of an innovative contraception practice among rural pharmacists","volume":"2","author":"Wong","year":"2014","journal-title":"Pharmacy"},{"key":"2025101814181084000_12.10.e063370.20","unstructured":"Government of Canada, S. C . Focus on geography series, 2011 census. Available: https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/as-sa\/fogs-spg\/select-Geo-Choix.cfm?Lang=Eng&GK=CMA&TOPIC=1 (2012)"},{"key":"2025101814181084000_12.10.e063370.21","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025101814181084000_12.10.e063370.22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/2159676X.2019.1628806","article-title":"Reflecting on reflexive thematic analysis","volume":"11","author":"Braun","year":"2019","journal-title":"Qual Res Sport Exerc Health"},{"key":"2025101814181084000_12.10.e063370.23","unstructured":"Statistics Canada . Population and Dwelling count highlight tables, 2016 census. Available: https:\/\/www12.statcan.gc.ca\/census-recensement\/2016\/dp-pd\/hlt-fst\/ pd-pl\/Table.cfm?Lang=Eng&T=101&S=50&O=A [Accessed 20 Jul 2021]."},{"key":"2025101814181084000_12.10.e063370.24","unstructured":"Canadian Pharmacists Association . \"MIFEGYMISO: Access and Coverage in Canada: updated June 11, 2019. Available: https:\/\/www.pharmacists.ca\/cpha-ca\/assets\/File\/cpha-on-the- issues\/Mifegymiso_Access_Scan.pdf"},{"key":"2025101814181084000_12.10.e063370.25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1503\/cmaj.045019","article-title":"Effects of making emergency contraception available without a physician's prescription: a population-based study","volume":"172","author":"Soon","year":"2005","journal-title":"CMAJ"},{"key":"2025101814181084000_12.10.e063370.26","first-page":"870","article-title":"Emergency contraception","volume":"34","author":"Dunn","year":"2003","journal-title":"J Obstet Gynaecol"},{"key":"2025101814181084000_12.10.e063370.27","doi-asserted-by":"publisher","DOI":"10.1363\/3901307"},{"key":"2025101814181084000_12.10.e063370.28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/17151635211005503","article-title":"Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing","volume":"154","author":"Rebic","year":"2021","journal-title":"Can Pharm J"},{"key":"2025101814181084000_12.10.e063370.29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.japh.2021.06.017","article-title":"Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion","volume":"61","author":"Kaller","year":"2021","journal-title":"J Am Pharm Assoc"},{"key":"2025101814181084000_12.10.e063370.30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/AOG.0000000000004312","article-title":"Medication abortion with pharmacist dispensing of mifepristone","volume":"137","author":"Grossman","year":"2021","journal-title":"Obstet Gynecol"},{"key":"2025101814181084000_12.10.e063370.31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.contraception.2021.03.022","article-title":"Expanding access to medication abortion through pharmacy dispensing of mifepristone: primary care perspectives from Illinois","volume":"104","author":"Rasmussen","year":"2021","journal-title":"Contraception"},{"key":"2025101814181084000_12.10.e063370.32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.contraception.2021.04.029","article-title":"Medication abortion: Advocating for mifepristone dispensing by pharmacists","volume":"104","author":"Stone","year":"2021","journal-title":"Contraception"},{"key":"2025101814181084000_12.10.e063370.33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmacy7030106","article-title":"Community-Based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States","volume":"7","author":"Goode","year":"2019","journal-title":"Pharmacy"},{"key":"2025101814181084000_12.10.e063370.34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/1467-9566.12739","article-title":"'I expected just to walk in, get my tablets and then walk out': on framing new community pharmacy services in the English healthcare system","volume":"40","author":"Latif","year":"2018","journal-title":"Sociol Health Illn"},{"key":"2025101814181084000_12.10.e063370.35","unstructured":"Svarcaite J . Overview of community pharmacy services in Europe. Brussels: Pharmaceutical Group of the European Union, 2016."},{"key":"2025101814181084000_12.10.e063370.36","doi-asserted-by":"crossref","first-page":"i30","DOI":"10.1093\/fampra\/cmab083","article-title":"The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic","volume":"38","author":"Ennis","year":"2021","journal-title":"Fam Pract"},{"key":"2025101814181084000_12.10.e063370.37","unstructured":"Statistics Canada . Government of Canada, \u201cPopulation estimates quarterly,\u201d, 2022. Available: https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000901 [Accessed 8 Jul 2022]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-063370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:18:19Z","timestamp":1760822299000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-063370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,7]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/bmjopen-2022-063370"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-063370","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}